US Broker Ratings

Dynavax Technologies Corp (DVAX) Stock Analysis: Exploring a 124.85% Potential Upside for Investors

Dynavax Technologies Corporation (NASDAQ: DVAX) has been a company of interest for investors seeking opportunities in the healthcare sector, particularly within the niche of specialty and generic drug manufacturing. With..

Opko Health, Inc. (OPK) Stock Analysis: A High-Stakes Bet with 129% Potential Upside

Opko Health, Inc. (NASDAQ: OPK), a prominent player in the healthcare sector, is making waves in the diagnostics and pharmaceuticals industries. Headquartered in Miami, Florida, the company has made significant..

BGM Group Ltd. (BGM) Stock Analysis: Navigating Challenges with a Diverse Product Portfolio

BGM Group Ltd. (BGM), a company nestled in the healthcare sector, specifically within the drug manufacturers – specialty & generic industry, is making waves with its diverse range of pharmaceutical..

NeoGenomics, Inc. (NEO) Stock Analysis: Exploring Growth Potential with 9.89% Upside

In the ever-evolving healthcare sector, NeoGenomics, Inc. (NEO) stands out as a prominent player within the diagnostics and research industry. With a robust presence in the United States and the..

89bio, Inc. (ETNB) Stock Analysis: Unveiling a 97% Potential Upside in the Biotech Sector

For investors keeping a keen eye on the biotech sector, 89bio, Inc. (NASDAQ: ETNB) presents an intriguing opportunity. With a market capitalization of $2.21 billion, this clinical-stage biopharmaceutical company is..

Premier, Inc. (PINC) Stock Analysis: Examining the 3.02% Dividend Yield Amidst a Challenging Revenue Landscape

Investors eyeing opportunities in the healthcare sector may want to consider Premier, Inc. (NASDAQ: PINC), a firm that operates in the health information services industry. With a market capitalization of..

The Pennant Group, Inc. (PNTG) Stock Analysis: Exploring a 31.66% Potential Upside

The Pennant Group, Inc. (NASDAQ: PNTG), a key player in the healthcare sector, is currently drawing investor attention with a compelling 31.66% potential upside, according to analyst projections. Operating within..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Exploring a 22.90% Potential Upside

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a prominent player in the healthcare sector specializing in drug manufacturing with a focus on specialty and generic products, presents a compelling narrative for investors...

Evolent Health, Inc (EVH) Stock Analysis: Exploring an 87% Potential Upside in Healthcare Tech

Evolent Health, Inc (NASDAQ: EVH) stands out as a compelling opportunity for investors interested in the healthcare technology sector. Operating at the intersection of health information services and specialty care..

Centessa Pharmaceuticals (CNTA) Stock Analysis: A Biotech Play with 41% Upside Potential

Centessa Pharmaceuticals plc (NASDAQ: CNTA) has captured the attention of investors in the biotechnology sector, thanks to its promising pipeline and a notable potential upside. Headquartered in Altrincham, United Kingdom,..

Janux Therapeutics, Inc. (JANX) Stock Analysis: Exploring the 245% Upside Potential in Biotech

Janux Therapeutics, Inc. (NASDAQ: JANX), a clinical-stage biopharmaceutical company, is currently garnering significant attention in the biotech sector, with a striking potential upside of 245.29% according to analyst ratings. The..

Kymera Therapeutics, Inc. (KYMR) Stock Analysis: Strong Buy Ratings Propel a Promising 11.79% Upside

Kymera Therapeutics, Inc. (NASDAQ: KYMR) is capturing investors’ attention with its innovative approach in the biotechnology sector and a notable 11.79% potential upside. This Watertown, Massachusetts-based company, founded in 2015,..

agilon health, inc. (AGL) Stock Analysis: Evaluating the 32.56% Potential Upside Amidst Market Challenges

agilon health, inc. (NYSE: AGL), a prominent player in the healthcare sector, specifically within the medical care facilities industry, is currently navigating a complex financial landscape. With a market capitalization..

DENTSPLY SIRONA Inc. (XRAY) Investor Outlook: Exploring a 33.50% Upside Potential Amidst Dividend Stability

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a prominent player in the healthcare sector with a focus on medical instruments and supplies, is capturing investor attention with its substantial dividend yield and..

Brookdale Senior Living Inc. (BKD) Stock Analysis: Navigating Challenges with 4.80% Revenue Growth and Strategic Positioning

Brookdale Senior Living Inc. (NYSE: BKD) stands as a significant player in the healthcare sector, specifically within the medical care facilities industry in the United States. With a substantial market..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: A Biotech Gem with Strong Revenue Growth and Potential Upside

Investors with an eye on the biotechnology sector would do well to consider Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS). This Irvine, California-based biopharmaceutical company focuses on developing therapeutic candidates for eye..

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: Exploring a 14% Upside Potential in the Biotech Sector

For investors eyeing opportunities in the healthcare sector, Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) presents a compelling case. As a biotechnology company focused on innovative treatments in cellular metabolism, Agios Pharmaceuticals..

BioLife Solutions, Inc. (BLFS) Stock Analysis: Unpacking an 18% Upside Potential in the Booming Cell and Gene Therapy Sector

BioLife Solutions, Inc. (NASDAQ: BLFS) stands out as a compelling investment opportunity within the healthcare sector, particularly for those with an eye on the burgeoning field of cell and gene..

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: A Balanced Outlook with Revenue Growth and Analyst Consensus

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) stands out in the healthcare sector, particularly within the medical care facilities industry. Headquartered in Atlanta, Georgia, Aveanna provides a diversified home care platform..

Evotec SE (EVO) Investor Outlook: Unpacking the 49.78% Potential Upside

Evotec SE (EVO), a prominent player within the healthcare sector, particularly in the specialty and generic drug manufacturing industry, offers investors intriguing prospects from its headquarters in Hamburg, Germany. With..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds